Clin2
NCT07826364Possibly a fitNot yet recruiting

Testing a new obesity treatment for safety and weight loss

Body Weight Management

Part of Hormones & metabolism clinical trials.

This trial tests a new injectable medication called SHR-1179 to see if it is safe and can help with weight loss. It is a placebo-controlled study, meaning some participants receive the drug and others receive an inactive shot, and no one knows which they get.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
50 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You must be between 18 and 60 years old.
  • Your BMI must be between 28 and 35 (considered overweight or obesity).
  • You must not have had major weight changes (more than 5%) in the last 3 months.
  • You must not have used weight-loss drugs or GLP-1 medications (like Ozempic) in the last 3 months.
  • You need to be generally healthy and able to follow study procedures.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07280936Recruiting· Phase 1
Study of SHR-2906 in healthy people and those with obesity

This trial tests a new injection called SHR-2906, first in healthy people to check safety, then in people with obesity to see how well it works. It may help with weight management.

Hangzhou, Zhejiang
NCT07690826Not yet recruiting· Phase 2
Weight loss injection study for adults with obesity

This study tests an investigational injection called HRS-4729 to see if it helps people with obesity lose weight. It may offer a new treatment option for those who have been trying to manage their weight with diet and exercise.

Shanghai, Shanghai Municipality
NCT07824804Not yet recruiting· Phase 1
Safety study of an injection for weight management

This study tests a new injection (MWN117) in healthy people and in people with obesity. It aims to see if the drug is safe and how the body handles it, which may eventually help with weight management.

Kunming, Yunnan
NCT07716241Not yet recruiting· Phase 1
Study of an investigational injection for weight management in healthy or overweight adults

This study tests a new injected medicine (called HS-20136-2) to see if it is safe and how the body handles it. It is an early (phase 1) trial that includes healthy people and people with overweight, and the goal is to learn about possible effects on weight and metabolism.

Hefei
NCT07873645Not yet recruiting· Phase 1
Testing an experimental injection for weight management

This study tests an experimental injection called UBT37034 to see if it is safe and how the body handles it. It is for people who are overweight but otherwise healthy. By joining, you could help find new ways to help with weight control—and you'll receive close monitoring and care.

NCT07557355Not yet recruiting· Phase 1/Phase 2
Weight loss study for people who are overweight or obese

This study tests a new medicine, SRSD384, to see if it can help people who are overweight or obese lose weight. It is an early-stage trial, so the focus is on safety and how well the medicine works.

Charlestown, New South Wales

Hear when a new Body Weight Management trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.